The following trials provide information to treat various types of cancer and infectious disease, both for ongoing and completed clinical trials. For more information on our oncology therapy area please click here or for our infection therapy area please click here.
- collapse An NIS Registry for the Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic NSCLC (Stage IIIB/IV Non-small Cell Lung Cancer)
- collapse Iressa Follow-up Trial
- collapse Comparing Efficacy between Anti-microtubule and Non-anti-microtubule as 3th Therapy after 2nd line EGFR-TKI therapy
- collapse Observational Retrospective trial on sequential hormonal therapy in patients with Prostate Cancer (SORSE)
- collapse A Phase I Study of Oral MK-2206 in Combination with Oral AZD6244 in Patients with Locally Advanced or Metastatic Solid Tumors
- collapse Phase I escalating dose modified Fibonacci sequence
- collapse A Randomized Phase II Trial of Temozolomide (TMZ) with/without Recentin (AZD2171) in Patients with unresectable Stage IV Malignant Melanoma.
- collapse Magnetic Resonance Spectroscopy in Gliobastoma
- collapse Irinotecan and AZD2171 in pts with met CRC
- collapse A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Phase III Study to Assess the Efficacy and Safety of Vandetanib (CAPRELSA) 300 mg in Patients with Papillary or Poorly Differentiated Thyroid Cancer That Is Either Locally Advanced or Metastatic Who Are Refractory or Unsuitable for Radioiodine (RAI) Therapy.
